A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer
Stopped early · Phase 3
Conditions studied: Non Small Cell Lung Cancer
In brief
The purpose of this study was to evaluate the safety and efficacy of ociperlimab in combination with tislelizumab compared to durvalumab in adults with stage III unresectable PD-L1-selected non-small cell lung cancer whose disease has not progressed after cCRT.
Key facts
- Study ID
- NCT04866017
- Run by
- BeiGene
- People needed
- 63
- Starts
- 2021-06-17
- Expected to finish
- 2023-10-17
- Last updated by the study team
- 2024-10-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- XCancer/Centeral Care Center — Bolivar, Missouri, United States
- Southern Medical Day Care Centre — Wollongong, New South Wales, Australia
- Townsville Hospital — Douglas, Queensland, Australia
- Lyell McEwin Hospital — Elizabeth Vale, South Australia, Australia
- Royal Hobart Hospital — Hobart, Tasmania, Australia
- Cabrini Hospital — Malvern, Victoria, Australia
- Gold Coast University Hospital — Gold Coast, Australia
- Hollywood Private Hospital — Perth, Australia
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Chongqing University Cancer Hospital — Chongqing, Chongqing Municipality, China
- Fujian Cancer Hospital — Fuzhou, Fujian, China
- Nanfang Hospital of Southern Medical University — Guangzhou, Guangdong, China
- The First Affiliated Hospital, Sun Yat-sen University — Guangzhou, Guangdong, China
- Hunan Cancer Hospital - GCP Office — Changsha, Hunan, China
- Nanjing First Hospital — Nanjing, Jiangsu, China
- The First Affiliated Hospital of Soochow University Branch Shizi — Suzhou, Jiangsu, China
- The First Affiliated Hospital of Nanchang University Branch Donghu — Nanchang, Jiangxi, China
- Jilin Cancer Hospital — Changchun, Jilin, China
- The First Hospital of Jilin University — Changchun, Jilin, China
- General Hospital of Ningxia Medical University — Yinchuan, Ningxia, China
- Shandong Cancer Hospital and Institute, Shandong First Medical University — Jinan, Shandong, China
- Fudan University Shanghai Cancer Center — Shanghai, Shanghai Municipality, China
- West China Hospital, Sichuan University — Chengdu, Sichuan, China
- Tianjin Medical University Cancer Institute & Hospital — Tianjin, Tianjin Municipality, China
- Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine — Hangzhou, Zhejiang, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.